Doxazosin
- Product NDC
- 70518-3965
- 11-digit product format
- 705183965
- Labeler code
- 70518
- Product ID
- 70518-3965_3bb3e30f-210c-291c-e063-6294a90a280b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA208719
- Marketing category
- ANDA
- Marketing start
- 2023-12-17
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXAZOSIN MESYLATE | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 86P6PQK0MU |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70518-3965-0 | Doxazosin | 30 in 1 BLISTER PACK | TABLET | 30 | | 4 |
| 70518-3965-1 | Doxazosin | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70518-3965 | DOXAZOSIN TABLET [REMEDYREPACK INC.] | 3 | Current NDC, 2 package rows | 20240503_ec06f008-37a1-4757-a3ee-0b4720912bc4.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70518-3965-0 | 70518396500 | 30 TABLET in 1 BLISTER PACK (70518-3965-0) | 30 tablet | 2023-12-17 | No | No | Current |
| 70518-3965-1 | 70518396501 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-3965-1) | 90 tablet | 2024-05-01 | No | No | Current |